Research at the AG Hilgendorf lab aims at investigating specific mutations and how they relate to cardiovascular diseases. Based on clinical observations, the team of scientists decided to deepen their understanding by using an hPSC model control experiment.
We identified hPSCs as an adequate tool to model clinical conditions in a controlled manner. To draw valid and meaningful conclusions that translate experimental results into scientific insights, we think it is important to ensure an adequate stability and quality of hPSCs.
As our experiment requires genetic manipulation of hPSCs, we speculated that unintended genomic changes might occur. Therefore, we wanted to confirm the absence of major genomic abnormalities in the hPSCs before we used them for the down-stream experiments.
Stem Genomics provides a very convenient and good quality service that makes genomic quality control easy. Communication is smooth and instructions are clear.
The AG Hilgendorf laboratory’s scientific interest lies in understanding the role of the immune system in cardiovascular disease and how modulation of the immune response affects disease outcome. The goal of our research is:
Join us LIVE for our webinar “Genomic stability made easy” to discover how Stem Genomics has turned cutting-edge technologies into easy testing solutions accessible to most labs.
Get expert opinions and user perspectives on our genomic stability assays in the context of iPSC research.
Happening on Tuesday, November 14, 6 pm CET
Please enter your e-mail address.